Tyrosinase activity in serum from patients with malignant melanoma
- PMID: 2564228
Tyrosinase activity in serum from patients with malignant melanoma
Abstract
A preparation procedure is presented for the determination of tyrosinase-catalysed stereo-specific dopa oxidase activity in serum. Purification is obtained by separation on a Phenyl-Sepharose hydrophobic interaction column, followed by Con-A-Sepharose chromatography. Five out of seven sera from patients with widespread melanoma metastases were found to contain detectable quantities of tyrosinase. There was no tyrosinase activity in seven sera from patients with other malignancies, nor in six other control sera from individuals without malignancies. One serum which showed high tyrosinase activity was processed as above and studied by SDS-PAGE. A dopa-reactive band with an apparent MW of 66 kD was present in the gel, i.e. at the same place as that of the soluble tyrosinase of cultured human malignant melanoma cells. The protein was found to have the same pI at isoelectric focusing, and eluted in the same way from the preparation columns used, as did soluble tyrosinase.
Similar articles
-
Serum tyrosinase in malignant disease, its activity, and the electrophoretic patterns of the enzyme as carried by immunoglobulins'.Cancer Res. 1979 Sep;39(9):3485-90. Cancer Res. 1979. PMID: 113092
-
Immunological determination of tyrosinase in sera of melanoma-bearing hamsters.Neoplasma. 1980;27(4):345-53. Neoplasma. 1980. PMID: 6779209
-
[Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors].Biokhimiia. 1991 Jun;56(6):1026-35. Biokhimiia. 1991. PMID: 1932336 Russian.
-
RT-PCR tyrosinase expression in the peripheral blood of melanoma patients.Expert Rev Mol Diagn. 2004 Sep;4(5):727-41. doi: 10.1586/14737159.4.5.727. Expert Rev Mol Diagn. 2004. PMID: 15347265 Review.
-
Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53.Integr Cancer Ther. 2011 Dec;10(4):328-40. doi: 10.1177/1534735410391661. Epub 2010 Dec 31. Integr Cancer Ther. 2011. PMID: 21196432 Review.
Cited by
-
[Serum markers for melanoma].Hautarzt. 2005 Feb;56(2):173-84; 185-6. doi: 10.1007/s00105-004-0893-2. Hautarzt. 2005. PMID: 15657726 German.
-
Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.Arch Dermatol Res. 2007 Mar;298(10):469-77. doi: 10.1007/s00403-006-0726-5. Arch Dermatol Res. 2007. PMID: 17221215 Free PMC article. Review.
-
Circulating serologic and molecular biomarkers in malignant melanoma.Mayo Clin Proc. 2011 Oct;86(10):981-90. doi: 10.4065/mcp.2011.0287. Mayo Clin Proc. 2011. PMID: 21964175 Free PMC article. Review.
-
The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions.Clin Rev Allergy Immunol. 1998 Fall;16(3):227-36. doi: 10.1007/BF02737633. Clin Rev Allergy Immunol. 1998. PMID: 9773250 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous